Literature DB >> 12918755

Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.

Ina Kötter1, Manfred Zierhut, Anja Eckstein, Reinhard Vonthein, Thomas Ness, Ilhan Günaydin, Bodo Grimbacher, Sabine Blaschke, Hans-Hartmut Peter, Lothar Kanz, Nicole Stübiger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12918755     DOI： 10.1007/0-306-48382-3_104

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  4 in total

Review 1.  Ophthalmic manifestations of rheumatologic disease: diagnosis and management.

Authors:  Carisa K Petris; Arghavan Almony
Journal:  Mo Med       Date:  2012 Jan-Feb

2.  Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease.

Authors:  K B Baker; N J Spurrier; A S Watkins; J R Smith; J T Rosenbaum
Journal:  Br J Ophthalmol       Date:  2006-08-16       Impact factor: 4.638

Review 3.  Knitting the Threads of Silk through Time: Behçet's Disease-Past, Present, and Future.

Authors:  Fahd Adeeb; Austin G Stack; Alexander D Fraser
Journal:  Int J Rheumatol       Date:  2017-09-10

4.  High Levels of Serum Ubiquitin and Proteasome in a Case of HLA-B27 Uveitis.

Authors:  Settimio Rossi; Carlo Gesualdo; Rosa Maisto; Maria Consiglia Trotta; Nadia Di Carluccio; Annalisa Brigida; Valentina Di Iorio; Francesco Testa; Francesca Simonelli; Michele D'Amico; Clara Di Filippo
Journal:  Int J Mol Sci       Date:  2017-02-26       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.